141 related articles for article (PubMed ID: 37061238)
1. [Giant cell tumour of bone in the rib cage treated with denosumab. A case report].
Serret Miralles P; Orellana Fernández R; Parra Parente T; García-Chamón Brígido RB; Carrera Salas R
Rev Esp Patol; 2023; 56(2):119-123. PubMed ID: 37061238
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
4. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
[TBL] [Abstract][Full Text] [Related]
5. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab.
Rosa D; Dias RB; Salvador JC; Borges A
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30196254
[TBL] [Abstract][Full Text] [Related]
6. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
[TBL] [Abstract][Full Text] [Related]
7. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
[No Abstract] [Full Text] [Related]
8. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
9. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
10. Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy.
Toda Y; Ishihara S; Kawai A; Yoshida A
Virchows Arch; 2023 Jul; 483(1):125-129. PubMed ID: 36447097
[TBL] [Abstract][Full Text] [Related]
11. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
Park MJ; Ganjoo KN; Ladd AL
J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
[TBL] [Abstract][Full Text] [Related]
12. Histopathological Features Of Denosumab Treated Giant Cell Tumours Of Bone "A Single Institutional Experience" At A Tertiary Care Center, Karachi.
Ali SM; Yaqoob N; Aftab Aslam K; Tauseef S; Ahmed SK; Jilani SAA; Jamal S
J Ayub Med Coll Abbottabad; 2022; 34(1):73-81. PubMed ID: 35466631
[TBL] [Abstract][Full Text] [Related]
13. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
14. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
Bilgetekin I; Mammadkhanli O; Basal FB; Kandemir O; Canbay S; Oksuzoglu B
Anticancer Drugs; 2020 Jun; 31(5):533-535. PubMed ID: 31743134
[TBL] [Abstract][Full Text] [Related]
15. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
Yi J; Lee YH; Kim SK; Kim SH; Song HT; Shin KH; Suh JS
J Orthop Sci; 2018 May; 23(3):570-577. PubMed ID: 29429890
[TBL] [Abstract][Full Text] [Related]
16. Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report.
Otani S; Nakayama R; Sekita T; Hirozane T; Asano N; Nishimoto K; Sasaki A; Okita H; Morioka H; Nakamura M; Matsumoto M
BMC Cancer; 2019 Sep; 19(1):872. PubMed ID: 31481040
[TBL] [Abstract][Full Text] [Related]
17. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
Kumar R; Mallya V; Mandal S; Tomar R; Khurana N; Maini L
J Cancer Res Ther; 2023; 19(3):768-772. PubMed ID: 37470608
[TBL] [Abstract][Full Text] [Related]
18. Denosumab for an inoperable giant cell tumour of the ischial bone.
Paul AG; See LP; Ohn MH; Ohn KM
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38110341
[TBL] [Abstract][Full Text] [Related]
19. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
Kinoshita H; Orita S; Yonemoto T; Ishii T; Iwata S; Kamoda H; Tsukanishi T; Inage K; Abe K; Inoue M; Norimoto M; Umimura T; Fujimoto K; Shiga Y; Kanamoto H; Furuya T; Takahashi K; Ohtori S
J Med Case Rep; 2019 Apr; 13(1):116. PubMed ID: 31023361
[TBL] [Abstract][Full Text] [Related]
20. Giant cell tumor of bone under Denosumab treatment.
Wendling D; Guillot X; Sondag M; Chaigneau L; Aubry S; Prati C
Joint Bone Spine; 2018 Jul; 85(4):491. PubMed ID: 28970075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
